BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 196039)

  • 61. A randomised double-blind clinical trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex corneal ulceration.
    Young BJ; Patterson A; Ravenscroft T
    Br J Ophthalmol; 1982 Jun; 66(6):361-3. PubMed ID: 7044411
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus.
    Coster DJ; McKinnon JR; McGill JI; Jones BR; Fraunfelder FT
    J Infect Dis; 1976 Jun; 133 Suppl():A173-7. PubMed ID: 819598
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The corneal penetration of trifluorothymidine, adenine arabinoside, and idoxuridine: a comparative study.
    O'Brien WJ; Edelhauser HF
    Invest Ophthalmol Vis Sci; 1977 Dec; 16(12):1093-1103. PubMed ID: 411765
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiviral agents.
    Hermans PE; Cockerill FR
    Mayo Clin Proc; 1983 Apr; 58(4):217-22. PubMed ID: 6339831
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical evaluation of adenine arabinoside (ara-A) against superficial herpetic keratitis (author's transl)].
    Shiota H; Inoue S; Matsumura K
    Nippon Ganka Gakkai Zasshi; 1978 Feb; 82(2):144-51. PubMed ID: 665447
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers.
    McGill J; Tormey P; Walker CB
    Br J Ophthalmol; 1981 Sep; 65(9):610-3. PubMed ID: 7028086
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of vidarabine and related compounds on corneal endothelium.
    Hull DS; Bowman K; Green K
    Invest Ophthalmol Vis Sci; 1977 Jun; 16(6):545-9. PubMed ID: 863615
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical evaluation of adenine arabinoside and idoxuridine in the treatment of ocular herpes simplex.
    Pavan-Langston D
    Am J Ophthalmol; 1975 Sep; 80(3 Pt 2):495-502. PubMed ID: 1099915
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prophylaxis and therapy of experimental ocular herpes simplex. Comparison of idoxuridine, adenine arabinoside, and hypoxanthine arabinoside.
    Pavan-Langston D; Langston RH; Geary PA
    Arch Ophthalmol; 1974 Nov; 92(5):417-21. PubMed ID: 4611395
    [No Abstract]   [Full Text] [Related]  

  • 70. In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside.
    Bryson YJ; Connor JD
    Antimicrob Agents Chemother; 1976 Mar; 9(3):540-3. PubMed ID: 176937
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.
    Crane LR; Milne DA; Sunstrum JC; Lerner AM
    Antimicrob Agents Chemother; 1984 Oct; 26(4):557-62. PubMed ID: 6083754
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Arabinosyl-N6-hydroxyadenine: a new potent antivirus drug.
    Lopez C; Giner-Sorolla A
    Ann N Y Acad Sci; 1977 Mar; 284():351-7. PubMed ID: 212981
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adenosine deaminase in herpes simplex virus induced corneal stromal disease.
    O'Brien WJ; Taylor JL; Brotman SJ
    Curr Eye Res; 1987 Jan; 6(1):13-8. PubMed ID: 3829699
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibitors of adenosine deaminase and the development of antiviral agents.
    Cohen SS
    Ann N Y Acad Sci; 1985; 451():204-14. PubMed ID: 2416257
    [No Abstract]   [Full Text] [Related]  

  • 75. Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.
    Schwartz PM; Novack J; Shipman C; Drach JC
    Biochem Pharmacol; 1984 Aug; 33(15):2431-8. PubMed ID: 6087827
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intraocular penetration of the soluble antiviral, Ara AMP.
    Pavan-Langston D; North RD; Geary PA; Kinkel A
    Arch Ophthalmol; 1976 Sep; 94(9):1585-8. PubMed ID: 962668
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine.
    Cermak-Mörth CM; Christian R; Unger FM
    Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885
    [No Abstract]   [Full Text] [Related]  

  • 78. Acyclovir and vidarabine monophosphate: comparison of iontophoretic and intravenous administration for the treatment of HSV-1 stromal keratitis.
    Hill JM; Kwon BS; Burch KD; Deback J; Whang I; Jones GT; Luke B; Harp R; Shimomura Y; Hull DS; Gangarosa LP
    Am J Med; 1982 Jul; 73(1A):300-4. PubMed ID: 6179415
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A).
    Schabel FM
    Chemotherapia (Basel); 1968; 13(6):321-38. PubMed ID: 4305653
    [No Abstract]   [Full Text] [Related]  

  • 80. [Effect of riodoxol on herpes simplex virus morphogenesis in experimental eye infection].
    Stebaeva LF; Nikolaeva IS; Pershin GN
    Vopr Virusol; 1982; (1):90-4. PubMed ID: 6280397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.